Journals / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2019 / Cilt: 6 - Sayı: 3

Pitriyazis Versikolor, Pitriyazis Rozea, Seboreik Dermatit ve Herpes Zoster’in Yaş, Cinsiyet, Mevsim ve Aylara Göre Dağılımının Karşılaştırılması

Pages
169–173
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our prevalence rates were calculated as PV: 1.08%, PR: 0.5%, SD: 0.6% and HZ: 0.01%.Conclusion: Although the seasonal effects of the existing diseases are determined, these findings should be supported by multicentre, prospective, large case studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: There are several studies reporting that pitriasis versicolor (PV), pitriasis rosea(PR), seborrheic dermatitis(SD) and herpes zoster(HZ) have been affected by seasonal changes.
📊
Key Findings & Data:In our study, we aimed to determine the relation ship of these diseases with age, gender, seasons and months.Methods: A total of 4946 patients diagnosed with PV, PR, SD or HZ who applied to our dermatology clinic between the dates, November 2015 and November 2018 were retrospectively evaluated from the automation system.Results: Of 4946 patients included in the study, 2833 were female (57.27%) and 2113 (42.73%) were male.We determined that PV was seen at the highest rate in summer, PR in Spring, HZ in fall and SD in fall and summer.
💡
Conclusion & Impact:Our prevalence rates were calculated as PV: 1.08%, PR: 0.5%, SD: 0.6% and HZ: 0.01%.Conclusion: Although the seasonal effects of the existing diseases are determined, these findings should be supported by multicentre, prospective, large case studies.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Pitriazis Versicolor · Pitriazis Rozea · Seboreik Dermatit

Abstract

Objective: There are several studies reporting that pitriasis versicolor (PV), pitriasis rosea(PR), seborrheic dermatitis(SD) and herpes zoster(HZ) have been affected by seasonal changes. In our study, we aimed to determine the relation ship of these diseases with age, gender, seasons and months.Methods: A total of 4946 patients diagnosed with PV, PR, SD or HZ who applied to our dermatology clinic between the dates, November 2015 and November 2018 were retrospectively evaluated from the automation system.Results: Of 4946 patients included in the study, 2833 were female (57.27%) and 2113 (42.73%) were male.We determined that PV was seen at the highest rate in summer, PR in Spring, HZ in fall and SD in fall and summer. Our prevalence rates were calculated as PV: 1.08%, PR: 0.5%, SD: 0.6% and HZ: 0.01%.Conclusion: Although the seasonal effects of the existing diseases are determined, these findings should be supported by multicentre, prospective, large case studies.

Özet

Amaç: Pitriazis Versicolor(PV), Pitriazis Rozea(PR), Seboreik Dermatit(SD) ve Herpes Zoster’(HZ)in mevsimsel değişikliklerden etkilendiği bildiren birkaç çalışma mevcuttur. Çalışmamızda bu hastalıkların yaş, cinsiyet, mevsim ve aylar ile olan ilişkisini saptamayı amaçladık Gereç ve yöntemler: Kasım 2015 - kasım 2018 tarihleri arasında dermatoloji polikliniğimize başvuran PV, PR, SD veya HZ tanısı alan toplam 4946 hasta otomasyon sisteminden retrospektif olarak değerlendirildi. Bulgular: Çalışmaya dahil edilen 4946 hastanın, 2833’si kadın (%57,27), 2113’u erkek (%42,73) idi. PV yaz, PR ilkbahar, HZ sonbahar ve SD sonbahar ve yaz aylarında en yüksek oranda görüldüğünü tespit ettik. Prevalans oranlarımız PV:%1,08, PR: %0,5, SD: %0,6 ve HZ: %0,01 olarak hesaplandı. Sonuç: Dermagrafik dağılımın, coğrafi şartların ve iklimin değişken olduğu ülkemizde hasta sayısı olarak en büyük seriye sahip olan çalışmamız literatüre destekleyecek bir kaynak olduğunu düşünmekteyiz.

🔖

Cite This Article

YALDIZ, M. (2019). Pitriyazis Versikolor, Pitriyazis Rozea, Seboreik Dermatit ve Herpes Zoster’in Yaş, Cinsiyet, Mevsim ve Aylara Göre Dağılımının Karşılaştırılması. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 6 - Sayı: 3, 169–173. https://ajindex.com/articles/144363

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Burke RC. Tineaversicolor: susceptibility factors and experimental infection in human beings. J InvestDermatol. 1961; 36: 389 402
  2. Faergemann J, Bernander S. Tinea versicolor and Pityrospor umorbiculare: a mycological investigation. Sabouraudia. 1979; 17: 171–179
  3. Fitzpatrick TB: Dermatology in general medicine. (McGraw-Hill, New York). 2003; 445-450
  4. Saçar T, Saçar H. Comparison of the Distributions of Seborrheic Dermatitis, Herpes Zoster and Pityriasis Rosea According to Seasons. Türkderm. 2010; 44: 65-8
  5. Chuang TY, Ilstrup DM, Perry HO, Kurland LT: Pityriasis rosea in Rochester, Minnesota, 1969 to1978. J Am Acad Dermatol. 1982;7: 80–89
  6. Stefanaki, I. ve Katsambas, A. Therapeutic update on sebborheic dermatitis. Skin TherLett. 2010;15(5): 1-4
  7. Donald H. Gilden, Randall J. Cohrs, Ravi Mahalingam. Viral Immunology. 2003;16:243-58
  8. Gershon AA: Varicella-ZosterVirusInfections. Pediatr Rev. 2008;29:5-11
  9. CrespoVE,Martos AO, Casańo AV, Fajardo FS.Malassezia globosaas the causative agent of pityriasis versicolor. British journal of Dermatology. 2000; 143: 799-803
  10. Roberts SOB. Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol. 1969;81: 315–311
  11. Abdul Razack EM, Thambiah AS. A clinical study of pityriasis versicolor in Madras. Sabouraudia. 1977; 14: 129–148
  12. Watanabe T, Kawamura T, Jacob SE. Pityriasis Rosea is Associated with Systemic Active Infection with Both Human Herpes virus-7 and Human Herpes virus. J InvestDermatol. 2002;119:793-7
  13. Harman M, Aytekin S, Akdeniz S, Inaloz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol. 1998;14:495-7
  14. Başkan EM,Turan H,Ercan İ,Yazıcı S.,Özkaya G, Sarıcaoğlu H. Pitriyazis Rozea Olgularında Demografik Ozellikler ve iklimsel Faktorlerin icelenmesi. Turkderm. 2011; 45: 97-9
  15. Bjornberg A, Hellgren L. Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol Suppl (Stockh). 1962;42:1-68
  16. Tay YK, Goh CL. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore. 1999;28:829-31
  17. Olumide Y: Pityriasis rosea in Lagos. Int J Dermatol. 1987;26:234-6
  18. Bjornberg A, Tegner E. Pityriasis rosea. In Freedberg IM, Eisen AZ, Wolff K(eds) Fitzpatrick's Dermatology in General Medicine, 5th edition, Mc Graw Hill NY, 1999:541-6
  19. Sahin MT, Ermertcan AT, Kapulu N, Öztürkcan S. Son 5 yılda pitiri